Skip to content
Curevo VaccineCurevo Vaccine
  • About
    • About Us
    • Management Team
  • Programs
    • Amezosvatein for Shingles
    • Amezosvatein for Chickenpox
  • Contact Us

News

{"cpt":"blog","style":"3","columns":"3","show":"6","order":"DESC","orderby":"DESC"}
  • All
  • Events
  • News
  • Press Releases
  • Vaccines
16 Oct, 2024
Press Releases

Curevo Vaccine Presents Amezosvatein Shingles Vaccine Data at ID Week

by curevovaccine
07 Apr, 2024
Press Releases

Dr. Chi Li Joins Curevo Vaccine as Chief Regulatory Officer

by curevovaccine
07 Jan, 2024
Press Releases

Curevo Vaccine Announces Positive Topline Results from Phase 2 Trial of Amezosvatein, a Next-Generation Vaccine for Shingles, Head-to-Head vs. Shingrix 

by curevovaccine
21 Dec, 2023
Press Releases

Curevo Vaccine to present at the 42nd Annual J.P. Morgan Healthcare Conference 

by curevovaccine
11 Apr, 2023
Press Releases

Guy De La Rosa, MD, Joins Curevo Vaccine as Chief Medical Officer

by curevovaccine
Curevo Vaccine Receives 2022 Best of Bothell Award
12 Dec, 2022
Press Releases

Curevo Vaccine Receives 2022 Best of Bothell Award

by curevovaccine
1 2 3 4

News

Curevo Vaccine logo white 158x90

___________________

A wholly owned subsidiary of Eli Lilly and Company

Curevo Inc.
18911 N Creek Pkwy #150
Bothell, WA 98011

+1.206.492.5722

Terms of Use
Privacy Policy
Cookie Policy

Consumer Health Privacy Notice

 © 2026 Curevo Inc.® All rights reserved.